BusinessVeritas Pharma Provides Comment on U.S. Attorney General Jeff Sessions MemoBy Nasdaq OMXJan 9, 2018, 8:05 AM UTC
BusinessVeritas Pharma Provides Year End Update on Company’s Activities to ShareholdersBy Nasdaq OMXJan 4, 2018, 11:14 PM UTC
BusinessVeritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory BoardBy Nasdaq OMXNov 29, 2017, 9:30 PM UTC
BusinessUS Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm CannevertBy Nasdaq OMXNov 28, 2017, 8:05 AM UTC
BusinessCannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UKBy Nasdaq OMXNov 22, 2017, 9:15 PM UTC
BusinessVeritas Pharma Initiates Cancer Research with Dr. Dmitri PetchkovskiBy Nasdaq OMXNov 14, 2017, 9:15 PM UTC
